Iborra, Marisa
García-Morales, Natalia
Rubio, Saoia
Bertoletti, Federico
Calvo, Marta
Taxonera, Carlos
Boscá-Watts, Marta Maia
Sierra, Mónica
Mancenido, Noemí
Beltrán, Belén
Nantes Castillejo, Óscar
García-Planella, Esther
Vera, Isabel
Alba, Cristina
Martí-Aguado, David
Ballester, María Pilar
Cano-Sanz, Noelia
Pajares-Villarroya, Ramón
Cerrillo, Elena
Cañada, Antonio
Nos, Pilar
Article History
Received: 14 May 2020
Accepted: 17 September 2020
First Online: 20 October 2020
Competing interests
: M. Iborra has received speaker, advisory board or research fees from MSD, Janssen, and Takeda, during the conduct of the study. N. García-Morales declares no conflicts of interest. S. Rubio declares no conflicts of interest. F. Bertoletti declares no conflicts of interest. M. Calvo has participated in educational activities, research projects and/or scientific meetings for MSD, Abbvie, Takeda, Janssen, Dr Falk, FAES farma, FERRING and Tilotts. C. Taxonera Samso has received speaker, advisory board or research fees from MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Dr. Falk Pharma, Amgen and Tillots. M.M. Bosca-Watts declares educational activities, research projects, scientific meetings and advisory boards sponsored by MSD, Ferring, Abbvie, Janssen and Takeda. M. Sierra attended and participated in sponsored courses and meetings and delivered presentations for laboratories such as MSD, Ferring, Abbvie, Janssen, Tillots, Faes, Shire and Takeda. N. Manceñido has been speaker for Takeda, Janssen and Abbvie and consulting for Ferring. B. Beltrán reports educational activities, research projects, scientific meetings and advisory boards sponsored by MSD, Ferring, Otsuka and Takeda. O. Nantes Castillejo reports educational activities and/or scientific meetings MSD, Abbvie y Pfizer. E. García-Planella has served as a speaker or received research or educational funding or advisory fees from MSD, AbbVie, Janssen, Ferring, Shire, Tillotts, and FAES. I. Vera has been a speaker, consultant and advisory member and/or has received funding from: MSD, Abbvie, Pfizer, Ferring, Shire Pharmaceuticals, Takeda y Janssen. C. Alba declares no conflict of interest. D. Martí Aguado declares no conflict of interest. M.P. Ballester declares no conflict of interest. N. Cano-Sanz declares no conflict of interest. R. Pajares-Villarroya declares no conflict of interest. E. Cerrillo declares no conflict of interest. A. Cañada declares no conflict of interest. P. Nos reports grants and personal fees from MSD, grants from Otsuka, AbbVie; personal fees from Takeda, Kern, Biogen, Ferring.